SCHOLAR ROCK HOLDING CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.33 USD | -3.19% |
|
-15.81% | -45.05% |
| May. 23 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
| May. 22 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 13.20 | 15.35 | 18.98 |
| Spread/Res. | -21.74% | -32.70% | -45.57% |
| Spread/Supp. | +10.13% | +10.13% | +69.90% |
| Support | 9.380 | 9.380 | 6.080 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SRRK Stock
- Charts Scholar Rock Holding Corporation
